Clinical Trials Directory

Trials / Completed

CompletedNCT07040787

Investigation of Drug-drug Interaction of HRS-5965 With Clopidogrel and Clarithromycin in Healthy Subjects

A Single-center, Single-arm, Fixed-sequence Drug-drug Interaction Study of HRS-5965 With Clopidogrel and Clarithromycin in Healthy Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Chengdu Suncadia Medicine Co., Ltd. · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The study is being conducted to compare the drug-drug interaction of HRS-5965 with clopidogrel and clarithromycin in healthy subjects.

Conditions

Interventions

TypeNameDescription
DRUGHRS-5965 CapsulesOral HRS-5965 capsules.
DRUGClopidogrelOral clopidogrel.
DRUGClarithromycinOral clarithromycin.

Timeline

Start date
2025-07-08
Primary completion
2025-08-17
Completion
2025-08-17
First posted
2025-06-27
Last updated
2025-08-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07040787. Inclusion in this directory is not an endorsement.

Investigation of Drug-drug Interaction of HRS-5965 With Clopidogrel and Clarithromycin in Healthy Subjects (NCT07040787) · Clinical Trials Directory